Biotech Values

[hirogen]

Hospital costs for the uninsured or underinsured at institutions such as MD Anderson may indeed be outrageous, but this has little to do with the problem addressed by the editorial: $100,000+ prices for cancer drugs that extend life very modestly.

I agree with the points in the editorial, but I also agree with Clark that the MD Anderson's need to look in the mirror. Cancer drug costs are escalating but then so is cost of overall cancer care of which drugs currently comprise a fairly low (~20% in 2010) percentage.

http://healthland.time.com/2013/02/20/bitter-pill-why-medical-bills-are-killing-us/